Feb 24, 2026 04:29AM
Feb 23, 2026 06:14PM
Nov 12, 2025 04:01PM
Aug 14, 2025 04:01PM
Aug 13, 2025 04:01PM
Aug 13, 2025 04:01PM
Aug 13, 2025 04:01PM MacroGenics Appoints Eric Risser as President and Chief Executive Officer
Aug 13, 2025 04:01PM
May 13, 2025 04:01PM
Mar 20, 2025 04:02PM
Nov 5, 2024 04:01PM
Oct 30, 2024 07:30AM
Oct 30, 2024 07:30AM
Oct 22, 2024 07:30AM Macrogenics (MGNX) Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA
Oct 22, 2024 07:30AM
Dec 19, 2023 05:30PM
Nov 6, 2023 04:01PM
Aug 9, 2023 04:01PM
May 9, 2023 04:01PM
Mar 22, 2023 01:23PM
Mar 22, 2023 01:22PM MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
Mar 22, 2023 01:22PM
Mar 15, 2023 04:01PM
Nov 18, 2022 05:16AM
Nov 17, 2022 06:10PM
Nov 17, 2022 06:10PM
Nov 3, 2022 04:01PM
Aug 8, 2022 04:01PM MacroGenics Provides Update on Corporate Progress and Second Quarter 2022 Financial Results
Jul 8, 2022 04:38PM
Jul 8, 2022 04:30PM
Jul 8, 2022 04:30PM
May 3, 2022 04:01PM
Feb 24, 2022 04:01PM
Feb 24, 2022 04:01PM
Nov 2, 2021 04:01PM MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results
Sep 16, 2021 05:47AM
Sep 16, 2021 02:45AM
Sep 16, 2021 02:45AM
Sep 7, 2021 04:34PM
Sep 7, 2021 04:30PM
Sep 7, 2021 04:30PM
Jul 29, 2021 04:01PM MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial Results
Jul 29, 2021 04:01PM
Jun 22, 2021 10:33AM
Apr 29, 2021 04:01PM
Feb 25, 2021 04:01PM
Feb 11, 2021 07:40AM
Feb 11, 2021 07:30AM
Feb 11, 2021 07:30AM MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
Jan 25, 2021 07:33AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All